| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |